Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Assets (2016 - 2025)

Dare Bioscience's Current Assets history spans 11 years, with the latest figure at $27.1 million for Q4 2025.

  • For Q4 2025, Current Assets rose 46.7% year-over-year to $27.1 million; the TTM value through Dec 2025 reached $27.1 million, up 46.7%, while the annual FY2025 figure was $27.1 million, 46.7% up from the prior year.
  • Current Assets reached $27.1 million in Q4 2025 per DARE's latest filing, up from $25.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $55.3 million in Q4 2021 to a low of $6.6 million in Q2 2025.
  • Average Current Assets over 5 years is $27.2 million, with a median of $22.3 million recorded in 2023.
  • Peak YoY movement for Current Assets: skyrocketed 691.76% in 2021, then crashed 68.3% in 2025.
  • A 5-year view of Current Assets shows it stood at $55.3 million in 2021, then decreased by 22.17% to $43.0 million in 2022, then crashed by 59.24% to $17.5 million in 2023, then rose by 5.15% to $18.4 million in 2024, then skyrocketed by 46.7% to $27.1 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Current Assets are $27.1 million (Q4 2025), $25.0 million (Q3 2025), and $6.6 million (Q2 2025).